car—t therapy is part of a revolution in cancer treatment which harnesses the power of the patient�*s own immune system to tackle their disease. there is a long way to go, but increased understanding of the genetics of cancer is delivering more and more targeted therapies with better outcomes. car—t is already available on the nhs for leukaemia patients up to the age of 25, but not for older adults because it's proved too toxic. scientists at university college london have refined car—t to reduce side effects, and after more trials hope it will be licensed for older patients. absolutely transformative. probably the biggest breakthrough in the last 20 years in _ malignant blood cancers. it'sjust an absolutel delight to be able to offer new therapies to these i patients who otherwise have no